These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23966881)

  • 21. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.
    Engeland K
    Cell Death Differ; 2018 Jan; 25(1):114-132. PubMed ID: 29125603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life or death: p53-induced apoptosis requires DNA binding cooperativity.
    Schlereth K; Charles JP; Bretz AC; Stiewe T
    Cell Cycle; 2010 Oct; 9(20):4068-76. PubMed ID: 20948308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses.
    Kenzelmann Broz D; Spano Mello S; Bieging KT; Jiang D; Dusek RL; Brady CA; Sidow A; Attardi LD
    Genes Dev; 2013 May; 27(9):1016-31. PubMed ID: 23651856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
    Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
    Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Non-Canonical Functions and Regulation of p53.
    Ranjan A; Iwakuma T
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hSSB1 regulates both the stability and the transcriptional activity of p53.
    Xu S; Wu Y; Chen Q; Cao J; Hu K; Tang J; Sang Y; Lai F; Wang L; Zhang R; Li SP; Zeng YX; Yin Y; Kang T
    Cell Res; 2013 Mar; 23(3):423-35. PubMed ID: 23184057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damage.
    Corn PG; El-Deiry WS
    Cancer Biol Ther; 2007 Dec; 6(12):1858-66. PubMed ID: 18087215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eRNAs are required for p53-dependent enhancer activity and gene transcription.
    Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
    Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.
    Ludwig RL; Bates S; Vousden KH
    Mol Cell Biol; 1996 Sep; 16(9):4952-60. PubMed ID: 8756654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.
    Cannell IG; Merrick KA; Morandell S; Zhu CQ; Braun CJ; Grant RA; Cameron ER; Tsao MS; Hemann MT; Yaffe MB
    Cancer Cell; 2015 Nov; 28(5):623-637. PubMed ID: 26602816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
    Walker KK; Levine AJ
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
    Heminger K; Markey M; Mpagi M; Berberich SJ
    Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
    Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
    Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.
    Li J; Tan M; Li L; Pamarthy D; Lawrence TS; Sun Y
    Neoplasia; 2005 Apr; 7(4):312-23. PubMed ID: 15967108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK; Lee JS; Sukumar S
    Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.